AI Boosts Progress in RNA Vaccine and Therapy Development
Researchers at MIT are leveraging artificial intelligence to enhance the delivery mechanisms of RNA vaccines and therapies, potentially revolutionizing disease treatment and prevention.
Researchers at MIT are leveraging artificial intelligence to enhance the delivery mechanisms of RNA vaccines and therapies, potentially revolutionizing disease treatment and prevention.
In a world where artificial intelligence increasingly drives innovation, Cloudian—a data storage company co-founded by an MIT alumnus—enables businesses to effectively manage the vast amounts of data AI models demand. Cloudian's solutions are designed to support the extensive data needs of machine learning systems while ensuring scalability and efficiency.
MIT scientists unveil VaxSeer, a cutting-edge AI tool that enhances the selection of flu vaccine strains by predicting virus evolution and antigenicity. This innovation aims to significantly improve the efficacy of vaccines and reduce dependence on traditional guessing methods.
Stay informed with curated insights delivered weekly to your inbox.